PAGLIACCI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 301
EU - Europa 141
AS - Asia 105
AF - Africa 17
SA - Sud America 8
Totale 572
Nazione #
US - Stati Uniti d'America 297
CN - Cina 34
IT - Italia 34
SG - Singapore 25
UA - Ucraina 20
DE - Germania 18
TR - Turchia 16
SE - Svezia 15
CI - Costa d'Avorio 14
RU - Federazione Russa 14
IE - Irlanda 13
VN - Vietnam 10
HK - Hong Kong 8
DK - Danimarca 7
BR - Brasile 6
FI - Finlandia 6
GB - Regno Unito 5
KR - Corea 5
CA - Canada 3
IN - India 3
JP - Giappone 3
MA - Marocco 3
CZ - Repubblica Ceca 2
ES - Italia 2
FR - Francia 2
PL - Polonia 2
AL - Albania 1
AR - Argentina 1
CL - Cile 1
LB - Libano 1
MX - Messico 1
Totale 572
Città #
Ashburn 41
Chandler 29
Dallas 20
Fairfield 20
Jacksonville 20
New York 15
Singapore 15
Abidjan 14
Dublin 13
Boardman 12
Houston 12
Beijing 10
Seattle 10
Centro 9
Wilmington 9
Hong Kong 8
Porto 8
Cambridge 6
Ho Chi Minh City 6
Munich 6
Chiaravalle 5
Los Angeles 5
Woodbridge 5
Ancona 4
Guangzhou 4
Lawrence 4
Princeton 4
San Mateo 4
The Dalles 4
Hefei 3
Montreal 3
Tokyo 3
Ankara 2
Ann Arbor 2
Boston 2
Brooklyn 2
Chennai 2
Columbus 2
Hanoi 2
London 2
Moscow 2
Olomouc 2
Orem 2
Phoenix 2
Rome 2
San Diego 2
San Francisco 2
Turku 2
Arqua Petrarca 1
Ascoli Piceno 1
Açailândia 1
Baoding 1
Birmingham 1
Biên Hòa 1
Bursa 1
Cerquilho 1
Chicago 1
Dalian 1
Grand Rapids 1
Hải Dương 1
Jequié 1
Kilburn 1
Lampa 1
Louisville 1
Mexico City 1
Mossoró 1
Nanning 1
Petrolina 1
Pune 1
Roubaix 1
Salt Lake City 1
Santa Clara 1
Seoul 1
Sidon 1
St Louis 1
Stockholm 1
Suzhou 1
São Paulo 1
Turin 1
Villa María 1
Warsaw 1
Washington 1
Xi'an 1
Totale 398
Nome #
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 146
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 133
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 118
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 110
Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID- 19 pandemic 79
Totale 586
Categoria #
all - tutte 2.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 5 6 5 6 16 9 1
2021/202233 5 7 0 0 0 3 1 2 2 5 2 6
2022/202371 5 12 4 6 7 10 0 0 20 2 3 2
2023/202456 10 3 1 7 5 18 3 4 0 0 0 5
2024/2025100 21 12 2 3 6 3 2 2 17 4 16 12
2025/2026160 29 22 20 39 32 18 0 0 0 0 0 0
Totale 586